Essex Bio-Technology Limited

SEHK:1061 株式レポート

時価総額：HK$1.4b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Essex Bio-Technology マネジメント

マネジメント 基準チェック /44

現在、CEO に関する十分な情報がありません。

主要情報

Haizhou Fang

最高経営責任者

HK$1.7m

報酬総額

CEO給与比率97.5%
CEO在任期間no data
CEOの所有権0.9%
経営陣の平均在職期間23.4yrs
取締役会の平均在任期間3.8yrs

経営陣の近況

How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?

Feb 15
How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?

Recent updates

Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement

May 06
Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement

Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)

Mar 21
Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)

Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet

Dec 07
Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Dec 07
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04

Aug 25
Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04

Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?

Jun 22
Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?

Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055

May 02
Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055

Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055

Mar 30
Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Jun 29
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Is Essex Bio-Technology (HKG:1061) A Risky Investment?

Mar 31
Is Essex Bio-Technology (HKG:1061) A Risky Investment?

If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today

Mar 13
If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today

How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?

Feb 15
How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?

Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?

Jan 25
Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?

Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Jan 04
Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Dec 13
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters

Nov 23
Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters

CEO報酬分析

Essex Bio-Technology の収益と比較して、Haizhou Fang の報酬はどのように変化したか？
日付総報酬給与会社業績
Dec 31 2023HK$2mHK$2m

HK$275m

Sep 30 2023n/an/a

HK$266m

Jun 30 2023n/an/a

HK$256m

Mar 31 2023n/an/a

HK$241m

Dec 31 2022HK$2mHK$2m

HK$225m

Sep 30 2022n/an/a

HK$274m

Jun 30 2022n/an/a

HK$323m

Mar 31 2022n/an/a

HK$334m

Dec 31 2021HK$2mHK$2m

HK$346m

Sep 30 2021n/an/a

HK$339m

Jun 30 2021n/an/a

HK$332m

Mar 31 2021n/an/a

HK$275m

Dec 31 2020HK$2mHK$2m

HK$219m

Sep 30 2020n/an/a

HK$221m

Jun 30 2020n/an/a

HK$222m

Mar 31 2020n/an/a

HK$262m

Dec 31 2019HK$2mHK$737k

HK$303m

Sep 30 2019n/an/a

HK$282m

Jun 30 2019n/an/a

HK$262m

Mar 31 2019n/an/a

HK$246m

Dec 31 2018HK$2mHK$766k

HK$231m

Sep 30 2018n/an/a

HK$210m

Jun 30 2018n/an/a

HK$189m

Mar 31 2018n/an/a

HK$178m

Dec 31 2017HK$2mHK$721k

HK$167m

報酬と市場: Haizhouの 総報酬 ($USD 223.41K ) は、 Hong Kong市場 ($USD 359.13K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Haizhouの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Haizhou Fang (58 yo)

no data

在職期間

HK$1,744,587

報酬

Mr. Haizhou Fang serves as the Managing Director and Executive Director of Essex Bio-Technology Limited and served as its General Manager. Mr. Fang is qualified as a Senior Pharmaceutical Engineer (Profess...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Mia Je Ngiam
Founder & Chairmanno dataHK$3.23m52.74%
HK$ 724.3m
Haizhou Fang
MD & Executive Directorno dataHK$1.74m0.92%
HK$ 12.7m
Hian Leng Ngiam
Executive Director & Deputy MDno dataHK$1.80m0.36%
HK$ 4.9m
Lai Man Yau
Executive Director & Company Secretary23.4yrsHK$755.60k0.0081%
HK$ 111.4k
Qi Xue
Group Chief Scientific Officer6.2yrsデータなしデータなし

23.4yrs

平均在職期間

60yo

平均年齢

経験豊富な経営陣: 1061の経営陣は経験豊富で経験豊富です（平均在職期間は23.4年）。

取締役

名称ポジション在職期間報酬所有権
Mia Je Ngiam
Founder & Chairmanno dataHK$3.23m52.74%
HK$ 724.3m
Haizhou Fang
MD & Executive Directorno dataHK$1.74m0.92%
HK$ 12.7m
Hian Leng Ngiam
Executive Director & Deputy MD3.8yrsHK$1.80m0.36%
HK$ 4.9m
Lai Man Yau
Executive Director & Company Secretary3.8yrsHK$755.60k0.0081%
HK$ 111.4k
Chi Ying Fung
Independent Non Executive Director23yrsHK$250.00kデータなし
Mee Mooi Yeow
Independent Non Executive Director19.8yrsHK$220.00kデータなし
Man Sing Yan
Independent Non-Executive Directorless than a yearHK$128.33kデータなし

3.8yrs

平均在職期間

61yo

平均年齢

経験豊富なボード: 1061の 取締役会 は 経験豊富 であると考えられます ( 3.8年の平均在任期間)。